MannKind Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
May 05, 2016 17:00 ET
|
MannKind
VALENCIA, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at the Bank of America Merrill Lynch 2016 Health...
MannKind Corporation to Hold 2016 First Quarter Financial Results Conference Call on May 9, 2016
May 02, 2016 17:00 ET
|
MannKind
VALENCIA, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2016 first quarter financial results on Monday, May 9, 2016 and its management will...
Analyst Call Rescheduled to April 26, 2016
April 19, 2016 13:26 ET
|
MannKind
VALENCIA, Calif., April 19, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) has postponed its analyst call scheduled for today, April 19, 2016, due to the unavailability of...
MannKind Expands Commercial Capabilities With Two New Hires
April 19, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., April 19, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced two senior appointments to its commercial organization. Joining the...
MannKind to Discuss U.S. Commercialization Update for Afrezza®
April 11, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host an analyst call for the investment community to learn about the company’s general...
MannKind Regains Afrezza® Marketing Rights
April 05, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) has assumed responsibility for the worldwide development and commercialization of Afrezza®...
MannKind Corporation Reports 2015 Fourth Quarter and Full Year Financial Results
March 14, 2016 16:48 ET
|
MannKind
VALENCIA, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2015.For...
MannKind Announces Appointment of Michael Castagna as Chief Commercial Officer
March 14, 2016 16:00 ET
|
MannKind
VALENCIA, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that Michael E. Castagna, Pharm.D., has joined the company as its Chief...
MannKind Corporation to Hold 2015 Fourth Quarter and Full Year Financial Results Conference Call on March 14, 2016
March 07, 2016 18:15 ET
|
MannKind
VALENCIA, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will release its 2015 fourth quarter and full year financial results on Monday, March 14, 2016...
MannKind to Potentially File 2015 10-K Filing Extension
February 26, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced that it anticipates being unable to timely file its Annual Report on Form 10-K...